Publications by authors named "Barbara Claus"

Claim this Profile
T
Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost-benefit analysis.
Barbara O M Claus, Delphine De Smedt, Pieter A De Cock

J Antimicrob Chemother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysis.
Barbara Claus, Sabrina Commeyne, Marc Van de Casteele, Sylvie Rottey

Int J Clin Pharm· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life.
Tatjana Van Der Heggen, Franky M Buyle, Barbara Claus, Annemie Somers, Petra Schelstraete

Int J Clin Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices.
Liese Barbier, Steven Simoens, Caroline Soontjens, Barbara Claus, Arnold G Vulto

Pharmaceuticals (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of logarithmic dose banding of anticancer drugs on pharmacy compounding efficiency at Ghent University Hospital.
Barbara Claus, Kaat De Pourcq, Nele Clottens, Vibeke Kruse, Paul Gemmel

Eur J Hosp Pharm· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is pharmacovigilance of biologicals cost-effective?
Barbara Claus

Int J Clin Pharm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policies for biosimilar uptake in Europe: An overview.
Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Barbara Claus

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
Tiene Bauters, Barbara Om Claus, Koen Norga, Isabelle Huys, Steven Simoens

J Oncol Pharm Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with the Implementation of Clinical Pharmacy Services and Processes in a University Hospital in Belgium.
Annemie Somers, Barbara Claus, Koen Vandewoude, Mirko Petrovic

Drugs Aging· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients.
Barbara O M Claus, Sylvia Snauwaert, Filomeen Haerynck, Sabine Van Daele, Frans De Baets

Int J Clin Pharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of an electronic antimicrobial alert system in intensive care in dosing errors and pharmacist workload.
Barbara O M Claus, Kirsten Colpaert, Kristof Steurbaut, Filip De Turck, Dirk P Vogelaers

Int J Clin Pharm· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Drug shortages in the hospital: management, causes and budget impact].
Barbara Claus, Kim Pauwels, Mariëlle Baert, Jan Depoorter, Elfi De Weerdt

J Pharm Belg· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.
Barbara O M Claus, Hugo Robays, Johan Decruyenaere, Lieven Annemans

J Eval Clin Pract· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy.
Barbara O M Claus, Eric A Hoste, Kirsten Colpaert, Hugo Robays, Johan Decruyenaere

J Crit Care· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's in a drop? Optimizing strategies for administration of drugs in pediatrics.
Tiene Bauters, Barbara Claus, Elsie Willems, Johan De Porre, Joris Verlooy

Int J Clin Pharm· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.
Barbara O M Claus, Fien M R Vandeputte, Hugo Robays

Int J Clin Pharm· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin-induced red man syndrome in pediatric oncology: still an issue?
Tiene Bauters, Barbara Claus, Petra Schelstraete, Hugo Robays, Yves Benoit

Int J Clin Pharm· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.
Barbara Claus, Franky Buyle, Hugo Robays, Dirk Vogelaers

Antimicrob Agents Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial.
Kirsten Colpaert, Barbara Claus, Annemie Somers, Koenraad Vandewoude, Hugo Robays

Crit Care· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis